MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202638077354 A) filed by Pharmacyclics LLC on June 23, 2026, for The Use Of Inhibitors Of Bruton'S Tyrosine Kinase (btk).
Inventors include Buggy, Joseph, J.; Elias, Laurence; Fyfe, Gwen; Hedrick, Eric; Loury, David, J.; and Mody, Tarak, D..
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: THE USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK) Disclosed herein are methods for treating a cancer comprising: a. administering a Btk inhibitor to a subject sufficient to result in an increase or appearance in the blood of a subpopulation of lymphocytes defined by immunophenotyping; b. determining the expression profile of one or more biomarkers from one or more subpopulation of lymphocytes; and c. administering a second agent based on the determined expression profile.
Disclaimer: Curated by HT Syndication.
